AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,897,000 | -38.4% | 555,186 | 0.0% | 0.18% | -43.4% |
Q3 2021 | $6,329,000 | -28.8% | 555,186 | 0.0% | 0.33% | -17.0% |
Q2 2021 | $8,889,000 | -36.9% | 555,186 | -29.6% | 0.39% | -32.3% |
Q1 2021 | $14,089,000 | +29.1% | 788,410 | -2.4% | 0.58% | +24.4% |
Q4 2020 | $10,911,000 | +14.8% | 807,656 | 0.0% | 0.47% | -0.8% |
Q3 2020 | $9,506,000 | -20.3% | 807,656 | 0.0% | 0.47% | -38.7% |
Q2 2020 | $11,921,000 | +17.6% | 807,656 | +7.5% | 0.77% | +13.7% |
Q1 2020 | $10,138,000 | -37.4% | 750,974 | +12.1% | 0.68% | -35.1% |
Q4 2019 | $16,195,000 | +25.8% | 670,036 | 0.0% | 1.04% | -52.7% |
Q3 2019 | $12,878,000 | -23.6% | 670,036 | +17.5% | 2.21% | -6.5% |
Q2 2019 | $16,845,000 | -21.3% | 570,036 | +26.5% | 2.36% | -25.5% |
Q1 2019 | $21,409,000 | +31.6% | 450,714 | 0.0% | 3.17% | +38.2% |
Q4 2018 | $16,271,000 | -35.3% | 450,714 | +10.3% | 2.29% | +14.8% |
Q3 2018 | $25,147,000 | +194.5% | 408,562 | +223.2% | 2.00% | +132.6% |
Q2 2018 | $8,538,000 | +383.7% | 126,397 | +26.4% | 0.86% | +575.6% |
Q2 2015 | $1,765,000 | -86.6% | 100,000 | -76.2% | 0.13% | -88.7% |
Q1 2015 | $13,152,000 | +7.4% | 419,652 | 0.0% | 1.12% | +12.9% |
Q4 2014 | $12,250,000 | – | 419,652 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |